Healthcare/Life Sciences

Medical-device makers’ shares leap as procedures hold going sturdy

Ozempic maker Novo Nordisk reviews 62% surge in revenue

Philips to halt CPAP gross sales within the U.S. because it takes $393 million provision

SolarEdge to put off 16% of its workforce as a part of cost-cutting plan

The case for healthcare shares

Philadelphia Fed manufacturing facility gauge in damaging territory for fifth straight month

Sell AstraZeneca, says UBS, which upgrades European rivals together with GSK

Want to up your mind recreation? Here are some methods to fend off cognitive decline.

GSK to purchase bronchial asthma drug developer for as much as $1.4 billion in pipeline push

Nvidia dives deeper into AI drug growth with Amgen, Recursion partnerships